<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE281nnn/GSE281162/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281162</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>The Impact of PPARβ/ agonism/antagonism on human bone-marrow-derived Mesenchymal Stromal Cells</name><description>PPARβ/ -ligands are present in the acute respiratory syndrome (ARDS) lung in abundance. Mesenchymal Stromal Cells (MSCs) have shown poor results in ARDS-based clinical trials. In order to determine the potential impact of PPARβ/ agonism/antagonism on human bone-marrow-derived MSCs in vitro, we activated or inhibited the receptor on the cells and/or licensed them with 5ng/ml TNF⍺.</description><dates><publication>2026/05/06</publication></dates><accession>GSE281162</accession><cross_references><GSM>GSM8611972</GSM><GSM>GSM8611961</GSM><GSM>GSM8611971</GSM><GSM>GSM8611960</GSM><GSM>GSM8611974</GSM><GSM>GSM8611963</GSM><GSM>GSM8611962</GSM><GSM>GSM8611973</GSM><GSM>GSM8611970</GSM><GSM>GSM8611969</GSM><GSM>GSM8611968</GSM><GSM>GSM8611959</GSM><GSM>GSM8611965</GSM><GSM>GSM8611976</GSM><GSM>GSM8611964</GSM><GSM>GSM8611975</GSM><GSM>GSM8611967</GSM><GSM>GSM8611966</GSM><GPL>24676</GPL><GSE>281162</GSE><taxon>Homo sapiens</taxon><PMID>[42007763]</PMID></cross_references></HashMap>